World's Best Scientists 2026 revealed!
Thomas F. Schulz

Thomas F. Schulz

D-Index & Metrics

Immunology

D-Index
89
Citations
24578
World Ranking
1127
National Ranking
71

Medicine

D-Index
89
Citations
24598
World Ranking
12833
National Ranking
688

Thomas F. Schulz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas F. Schulz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 381 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas F. Schulz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas F. Schulz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 89 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas F. Schulz is affiliated with Hannover Medical School in Germany and has contributed extensively to the field of medicine, particularly focusing on infectious diseases and viral research.

Their research spans several key areas within medicine, with particular emphasis on:

  • Infectious Diseases
  • Epidemiology
  • Oncology
  • Molecular Biology
  • Immunology

Thomas F. Schulz's main topics of work include:

  • Cytomegalovirus and herpesvirus research
  • Viral-associated cancers and disorders
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Herpesvirus Infections and Treatments
  • Immune Cell Function and Interaction
  • Respiratory viral infections research

The scientist has published frequently in various academic venues. Key publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • mBio
  • Nature Communications
  • GeroScience

Some recent papers by or involving Thomas F. Schulz are:

  • Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch, 2021, Wellcome Open Research
  • Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2, 2021, Wellcome Open Research
  • The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines, 2022, mBio
  • Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods, 2020, Cellular and Molecular Immunology
  • Identification of host-pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank, 2022, Nature Communications

Frequent co-authors who have collaborated with Thomas F. Schulz include:

  • Lennart M. Roesner
  • Saskia C. Stein
  • Reinhold Förster
  • Lars Steinbrück
  • Peter Laux

Best Publications

  • Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

    D Whitby;C Boshoff;T Hatzioannou;R.A Weiss

  • Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells.

    C Boshoff;T F Schulz;M M Kennedy;A K Graham

  • Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

    G. R. Simpson;T. F. Schulz;D. Whitby;P. M. Cook

  • The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen.

    L Rainbow;G M Platt;G R Simpson;R Sarid

  • Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8)

    Thomas F. Schulz

  • HIV-associated lymphomas and gamma-herpesviruses

    Antonino Carbone;Ethel Cesarman;Michele Spina;Annunziata Gloghini

  • Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma

    Chris Boschoff;Chris Boschoff;Denise Whitby;Denise Whitby;Theodora Hatziionnou;Theodora Hatziionnou;Cyril Fisher;Cyril Fisher

  • Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity

    Ch. Hammer;B. Stepniak;A. Schneider;S. Papiol

  • Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents.

    Satoshi Mayama;Luis E. Cuevas;Julie Sheldon;Omar H. Omar

  • The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines

    Unknown

  • The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

    Gary J. Clements;Molly J. Price-Jones;Paul E. Stephens;Christopher Sutton

  • Growth control of activated, synchronized murine B cells by the C3d fragment of human complement.

    Fritz Melchers;Anna Erdei;Thomas Schulz;Manfred P. Dierich

  • Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors

    Patrizia Barozzi;Mario Luppi;Fabio Facchetti;Cristina Mecucci

  • Kaposi's Sarcoma-Associated Herpesvirus and Kaposi's Sarcoma in Africa

    Yuan Chang;John Ziegler;Henry Wabinga;Edward Katangole-Mbidde

  • Bone marrow failure associated with human herpesvirus 8 infection after transplantation.

    Mario Luppi;Patrizia Barozzi;Thomas F. Schulz;Gisella Setti

  • Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.

    Neil Renwick;Teysir Halaby;Gerrit J. Weverling;Nicole H.t.m. Dukers

  • The pleiotropic effects of Kaposi's sarcoma herpesvirus.

    Thomas F Schulz

  • Interassay Correlation of Human Herpesvirus 8 Serologic Tests

    Charles S. Rabkin;Thomas F. Schulz;Denise Whitby;Evelyne T. Lennette

  • Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene.

    Georgina M. Platt;Guy R. Simpson;Sibylle Mittnacht;Thomas F. Schulz

  • Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus.

    Mark Glenn;Lucille Rainbow;Frédéric Auradé;Andrew Davison

  • Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981–1996

    Mads Melbye;Pamela M. Cook;Henrik Hjalgrim;Kamilla Begtrup

  • Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch.

    Áine O'Toole;Verity Hill;Oliver G. Pybus;Alexander Watts

Frequent Co-Authors

Manfred P. Dierich
Manfred P. Dierich Innsbruck Medical University
Albert Heim
Albert Heim Hannover Medical School
Robin A. Weiss
Robin A. Weiss University College London
Andrew J. Davison
Andrew J. Davison University of Glasgow
Giuseppe Torelli
Giuseppe Torelli University of Modena and Reggio Emilia
Michael Stürzl
Michael Stürzl University of Erlangen-Nuremberg
Jaap Goudsmit
Jaap Goudsmit Harvard University
Dietmar Fuchs
Dietmar Fuchs Innsbruck Medical University
Ernst R. Werner
Ernst R. Werner Innsbruck Medical University
Michael Kracht
Michael Kracht University of Giessen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring immunology opens doors to various specialized online degree programs and career pathways in healthcare. Many students interested in advancing clinical expertise choose programs like the best pmhnp programs, which emphasize strong clinical placements for Psychiatric Mental Health Nurse Practitioners (PMHNP).

For those seeking affordable education options, the cheapest psychiatric nurse practitioner programs offer accessible routes to specialize without compromising quality.

Career outlook in nursing specialties connected to immunology can be lucrative. Understanding the dnp salary by state helps prospective students evaluate the financial rewards associated with Doctor of Nursing Practice degrees across different regions.

Additionally, transitioning from family nursing to more acute care settings is a viable option through focused programs. Guidance on how to shift roles is detailed in acute care nurse practitioner programs, broadening career opportunities in immunology-related patient care.

Best Scientists Citing Thomas F. Schulz

Trending Scientists

Recently Published Articles